共 50 条
- [1] Treatment outcomes in patients with large B-cell lymphoma after progression to chimeric antigen receptor T-cell therapy [J]. HEMASPHERE, 2024, 8 (05):
- [2] Loncastuximab tesirine for diffuse large B-cell lymphoma [J]. DRUGS OF TODAY, 2021, 57 (12) : 733 - 743